Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 1, 2026 | Capital Blue Cross | Prostatic Urethral LiftPayerPolicy · CAPBLUE-MP-1.147 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Prostate Artery EmbolizationPayerPolicy · CAPBLUE-MP-4.051 | New policy |
|---|
| Aug 1, 2026 | Capital Blue Cross | Preimplantation Genetic TestingPayerPolicy · CAPBLUE-MP-7.009 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Postsurgical Home Use of Limb Compression Devices for Venous Thromboembolism ProphylaxisPayerPolicy · CAPBLUE-MP-6.053 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Pharmacogenomic and Metabolite Markers for Patients Treated with ThiopurinesPayerPolicy · CAPBLUE-MP-2.218 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Peripheral Subcutaneous Field Stimulation (PSFS)PayerPolicy · CAPBLUE-MP-1.141 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Orthopedic Applications of Stem Cell Therapy (Including Allograft and Bone Substitute Products Used with Autologous Bone Marrow)PayerPolicy · CAPBLUE-MP-2.080 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Orthopedic Applications of Platelet Rich PlasmaPayerPolicy · CAPBLUE-MP-4.039 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Optical Coherence Tomography (OCT) of the Anterior Eye SegmentPayerPolicy · CAPBLUE-MP-2.085 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Ophthalmologic Techniques That Evaluate the Posterior Eye SegmentPayerPolicy · CAPBLUE-MP-2.056 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Open and Thoracoscopic Approaches to Treat Atrial Fibrillation and Atrial Flutter (Maze and Related Procedures)PayerPolicy · CAPBLUE-MP-2.083 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Noninvasive Imaging for the Evaluation and Monitoring of Patients with Chronic Liver DiseasePayerPolicy · CAPBLUE-MP-2.252 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Noninvasive Fetal RHD Genotyping Using Cell-Free Fetal DNAPayerPolicy · CAPBLUE-MP-2.261 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Noncontraceptive Use of Intrauterine Devices (IUDs)PayerPolicy · CAPBLUE-MP-7.026 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Next-Generation Sequencing For The Assessment of Measurable Residual DiseasePayerPolicy · CAPBLUE-MP-2.379 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Negative Pressure Wound Therapy in the Outpatient SettingPayerPolicy · CAPBLUE-MP-4.004 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Multimarker Serum Testing Related to Ovarian CancerPayerPolicy · CAPBLUE-MP-2.270 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Multicancer Early Detection TestingPayerPolicy · CAPBLUE-MP-2.387 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Molecular Testing in the Management of Pulmonary NodulesPayerPolicy · CAPBLUE-MP-2.375 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Molecular Testing for The Management of Pancreatic Cysts and Solid Pancreaticobiliary LesionsPayerPolicy · CAPBLUE-MP-2.266 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Molecular Panel Testing of Cancers to Identify Targeted TherapiesPayerPolicy · CAPBLUE-MP-2.259 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Molecular Markers in Fine Needle Aspirates of the ThyroidPayerPolicy · CAPBLUE-MP-2.275 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Medical Treatments of Autism Spectrum DisordersPayerPolicy · CAPBLUE-MP-2.304 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Measurement of Exhaled Nitric Oxide in the Diagnosis and Management of Asthma and Other Respiratory DisordersPayerPolicy · CAPBLUE-MP-4.038 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Magnetic Resonance-Guided Focused UltrasoundPayerPolicy · CAPBLUE-MP-5.053 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Lower Limb ProsthesesPayerPolicy · CAPBLUE-MP-6.042 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Low Level Laser TherapyPayerPolicy · CAPBLUE-MP-1.097 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Low Intensity Pulsed Ultrasound Fracture Healing DevicePayerPolicy · CAPBLUE-MP-6.021 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Laparoscopic, Percutaneous, and Transcervical Techniques for Uterine Fibroid MyolysisPayerPolicy · CAPBLUE-MP-7.027 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Laboratory and Genetic Testing for Use of 5-Flourouracil in Patients with CancerPayerPolicy · CAPBLUE-MP-2.354 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Knee BracesPayerPolicy · CAPBLUE-MP-6.012 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | KIF6 Genotyping for Predicting Cardiovascular Risk and/or Effectiveness of Statin TherapyPayerPolicy · CAPBLUE-MP-2.309 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | JAK2, MPL, and CLR Mutation Analysis in Myeloproliferative NeoplasmsPayerPolicy · CAPBLUE-MP-2.281 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Investigational Miscellaneous Genetic and Molecular TestsPayerPolicy · CAPBLUE-MP-2.277 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Invasive Prenatal (Fetal) Diagnostic TestingPayerPolicy · CAPBLUE-MP-2.278 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Intraosseous Basivertebral Nerve AblationPayerPolicy · CAPBLUE-MP-1.124 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Intraoperative Neurophysiologic Monitoring (Sensory Evoked Potentials, Motor Evoked Potentials, EEG Monitoring)PayerPolicy · CAPBLUE-MP-2.030 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Intraocular Radiotherapy for Age-Related Macular DegenerationPayerPolicy · CAPBLUE-MP-2.389 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Intraocular Lenses, Spectacle Correction,and Iris ProsthesisPayerPolicy · CAPBLUE-MP-6.058 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Interferential Current StimulationPayerPolicy · CAPBLUE-MP-6.047 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Inpatient Interfacility TransfersPayerPolicy · CAPBLUE-MP-3.019 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Implantable Bone-Conduction and Bone-Anchored Hearing Prosthetic DevicesPayerPolicy · CAPBLUE-MP-1.019 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Hospital Beds and AccessoriesPayerPolicy · CAPBLUE-MP-6.001 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Hematopoietic Cell Transplantation in the Treatment of Germ-Cell TumorsPayerPolicy · CAPBLUE-MP-9.052 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Hematopoietic Cell Transplantation for Primary AmyloidosisPayerPolicy · CAPBLUE-MP-9.045 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Hematopoietic Cell Transplantation for Plasma Cell Dyscrasias, Including Multiple Myeloma and POEMS SyndromePayerPolicy · CAPBLUE-MP-9.044 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Hematopoietic Cell Transplantation for Non-Hodgkin LymphomasPayerPolicy · CAPBLUE-MP-9.042 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Hematopoietic Cell Transplantation for Miscellaneous Solid Tumors in AdultsPayerPolicy · CAPBLUE-MP-9.048 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Hematopoietic Cell Transplantation for Hodgkin LymphomaPayerPolicy · CAPBLUE-MP-9.043 | Metadata changed |
|---|
| Aug 1, 2026 | Capital Blue Cross | Hematopoietic Cell Transplantation for Epithelial Ovarian CancerPayerPolicy · CAPBLUE-MP-9.047 | Metadata changed |
|---|